Oncology

The Monash Health Department of Oncology provides more than 1.5 million residents of southern Melbourne with access to world leading cancer treatment over four locations within the Monash Health service:

Moorabbin Hospital: Breast cancer, GI cancer, GU cancer, Lung cancer

Dandenong Hospital: General Oncology, Geriatric Oncology

Casey Hospital: General Oncology

Monash Health Translation Precinct (MHTP building Level 3). Monash Medical Centre, Clayton: Cancer Clinical Trials

Our Services

Cancer patients receive care from diagnosis to treatment and follow-up support. Through collaborative multidisciplinary team framework we provide the Medical Oncology aspect of cancer care, integrating with teams from surgical and radiation oncology and Palliative and Supportive care.

Our Staff


Department Head

Prof. Eva Segelov MBBS (Hons 1) PhD FRACP

Professor/Director of Oncology
Gastrointestinal Cancers Neuroendocrine Tumours

Senior Leadership Team

A/Prof. Arun Azad MBBS FRACP PhD
Head of Oncology Clinical Trials
Genitourinary Cancer

A/Prof. Michael Franco MBBS FRACP FAChPM
Head of Oncology Operations & Education
Palliative Medicine Breast & GI Cancer

A/Prof. Jake Shortt BMedSc MBChB FRACP FRCPA PhD
Head of Haematology Research

Dr. Michelle White MBBS GDipPallMed FRACP
Head of Oncology Quality & Safety, Breast Cancer

Senior Medical Staff (listed in alphabetical order)

Dr. Muhammad Alamgeer MBBS MD MRCP FRACP
Lung, Head & Neck Cancer

Dr. Geraldine Goss MBBS FRACP MD MMED
Gynaecological Cancers

Dr Daphne Day MBBS (Hons), FRACP
Breast & Head and Neck Cancer and Phase 1 trials

Dr. Marion Harris MBBS FRACP
Director of Familial Cancer, GI and Breast Cancer

Dr. Edmond Kwan MBBS FRACP
Genitourinary Cancer

Dr. Ben Markman MBBS FRACP
Phase 1 Trials, Lung, Gastrointestinal Cancers

Dr. David Pook BMedSci (Hons) MBBS FRACP MD
Genitourinary Cancer

Dr. Ranjana Srivastava MBBS FRACP
Breast, Gastrointestinal Cancers, Geriatric Oncology

A/Prof. Andrew Strickland MBBS FRACP
Gastrointestinal Cancers


Mrs. Irina Arzhintar
Acting Unit Manager

Ms. Cheryl-Ann Hawkins
Study Coordinator

Ms. Penny McGuire
Study Coordinator

Ms. Chris Brooks
Study Coordinator

Ms. Louise Davis
Study Coordinator

Ms. Chris Poole
Study Coordinator

Ms. Laima Muceneikas
Study Coordinator

Ms. Lindsay Thompson
Study Coordinator

Ms. Shelley Firth
Study Coordinator

Ms. Lisa Robinson
Study Coordinator

Ms. Kim Brewin
Study Coordinator

Ms. Frances Bishop
Study Coordinator

Ms. Stephanie Kaladis
Lab Scientist

Ms. Joanna Maggs
Ethics Submission Specialist

Ms. Sabah Saad
Ethics Submission Specialist

Ms. Isabel Nehma
Clinical Trial Assistant

Ms. Joyce Zheng
Clinical Trial Assistant

Ms. Kanan Gill Sharma
Clinical Trial Assistant

Ms. Lauren Curtain
Clinical Trial Assistant


Ms. Annette McClellan
Oncology department Secretary/PA to Professor Segelov.
E: Annette.McClellan@monashhealth.org
P: +61 3 8572 2392

 

Department Publications

2017
Szczepny A, Rogers S, Jayasekara WS, Park K, McCloy RA, Cochrane CR, Ganju V, Cooper WA, Sage J, Peacock CD, Cain JE. The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer. Oncogene. 2017 Jun 5.

Chan DL, Segelov E, Wong RS, Smith A, Herbertson RA, Li BT, Tebbutt N, Price T, Pavlakis N. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer. The Cochrane database of systematic reviews. 2017 Jun 27;6:CD007047.

Strosberg JR, Halfdanarson TR, Bellizzi AM, Chan JA, Dillon JS, Heaney AP, Kunz PL, O’Dorisio TM, Salem R, Segelov E, Howe JR. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors. Pancreas. 2017 Jul 1;46(6):707-14.

Chüeh AC, Liew MS, Russell PA, Walkiewicz M, Jayachandran A, Starmans MH, Boutros PC, Wright G, Barnett10 SA, Mariadason JM, John T. Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer. transfer. 2017 May 23;11:12.

Roy AC, Wattchow D, Astill D, Singh S, Pendlebury S, Gormly K, Segelov E. Uncommon Anal Neoplasms. Surgical oncology clinics of North America. 2017 Jan 31;26(1):143-61.

Sandler CX, Goldstein D, Horsfield S, Bennett BK, Friedlander M, Bastick PA, Lewis CR, Segelov E, Boyle FM, Chin MT, Webber K. Randomized evaluation of cognitive-behavioral therapy and graded exercise therapy for post-cancer fatigue. Journal of pain and symptom management. 2017 May 11.

Annala M, Nappi L, Azad AA, Mo F, Fazli L, Chi KN, Wyatt AW. Molecular Dissection of Complete Response to Receptor Tyrosine Kinase Inhibition in Type II Papillary Renal Cell Carcinoma. Clinical genitourinary cancer. 2017 Feb 1;15(1):e145-50.

Wein L, Rowe C, Brady B, Handolias D, Lipton L, Pook D, Stanley R, Haines I. Prevalence of systemic anticancer therapy for patients within the last 30 days of life: experience in a private hospital oncology group. Internal medicine journal. 2017 Mar 1;47(3):280-3.

Poon P, Shaw T, Franco M, Runacres F, William L, Yoong J. Successful large volume ‘lymphocentesis’ for refractory lymphoedema in lower and upper limbs. Internal Medicine Journal. 2017 May 1;47(5):607-.

Srivastava R. The Interpreter. N Engl J Med. 2017 Mar 2;376:812-3

For 2016 publications click here

Optimal Care Pathways for cancer patients

The optimal cancer care pathways (OCPs) describe the optimal cancer care for specific tumour types. They map the patient journey, aiming to foster an understanding of the whole pathway and its distinct components to promote quality cancer care and patient experiences.

Cancer: What to Expect? Information for patients at http://www.cancerpathways.org.au/

Information for clinicians at http://www.cancervic.org.au/for-health-professionals/optimal-care-pathways

 Cancer prevention

Between 30-50% of all cancer cases are preventable. Prevention offers the most cost-effective long-term strategy for the control of cancer. National policies and programmes should be implemented to raise awareness, to reduce exposure to cancer risk factors and to ensure that people are provided with the information and support they need to adopt healthy lifestyles.

http://www.who.int/cancer/prevention/en/

 

  

 

 

 

Contacts and Locations

 

Moorabbin Hospital
823-865 Centre Rd
Bentleigh East
+61 3 9928-8120

Clinical Trials Centre
Level 3, MHTP Building 
Monash Health
246 Clayton Rd, Clayton
+ 61 3 8572 2427

Dandenong Hospital
David St, Dandenong
+61 3 9554-8977

Casey Hospital
62-70 Kangan Drive
Berwick 3806
+61 3 8768 1200